Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global sleep apnea devices market size was valued at USD 4.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. Obstructive Sleep Apnea (OSA) is a sleep disorder with irregular breathing reducing oxygen supply to the brain. As per the Chest Physician estimates in 2019, approximately 170 million individuals in the U.S. were diagnosed with OSA. According to the European Respiratory Journal in 2018, the estimated prevalence of OSA in 50 European countries was approximately 175 million. Changing lifestyle, a growing geriatric population, and the rising prevalence of chronic disorders is contributing to the growing incidence of OSA. The growing prevalence of apnea in the geriatric population remains under diagnosis of OSA due to a lack of awareness amongst individuals and poor presentation of OSA. The increasing life expectancy amongst the global geriatric population is expected to contribute to the growing prevalence of sleep disorders.

As per the United Nations World Population Ageing Report in 2019, approximately 703 million individuals across the globe are aged 65 years and above. Similarly, as per the World Health Organization (WHO) estimates the proportion of the world’s geriatric population is expected to double from 12% in 2015 to 22% in 2050 and is expected to reach 2 billion individuals.

The occurrence of OSA in the geriatric population is growing and it affects 13.0% to 32.0% of the global geriatric population in 2020. Therefore, the growing geriatric population and rising awareness levels are anticipated to boost the adoption of sleep apnea devices. Changing lifestyles coupled with the growing prevalence of hypertension and obesity is contributing to the growing occurrence of sleep apnea.

As per CDC estimates in 2017 - 2018, the prevalence of obesity in the U.S. was 42.4.0% and as per CDC estimates in 2019, the prevalence of hypertension in the U.S. was 47.0% accounting for 116 million individuals. According to PubMed estimates in 2019, the prevalence of hypertension was recorded at 55%. As per Eurostat estimates in 2019, 36% of the European population is pre-obese and 17% of the European population is obese.

COVID-19 sleep apnea devices market impact: an increase of 6.3% market growth between 2020 and 2021

As per studies undertaken by Mayo Clinic, males are 2-3 times more susceptible to sleep apnea than females. the National Library of Medicine article published in August 2017 on the prevalence of OSA stated that OSA occurrence is found to be higher in men (90%) as compared to women (78%). The prevalence of OSA increases with increasing age and is expected to rise rapidly over the forthcoming years. The increasing patient pool diagnosed with OSA is anticipated to drive the demand for sleep apnea treatment devices.

The growing incidence rate of chronic conditions is expected to increase the burden of OSA. Comorbidities such as diabetes, hypertension, cardiovascular diseases, and obesity are commonly associated with OSA. Some of the characteristics of OSA are frequent episodes of apnea & hypopnea, the collapse of the airway, and irregularities in breathing which result in adverse effects on the body. As per studies, 73% of patients suffer from Sleep-disordered Breathing (SDB) who have been diagnosed with stable heart failure episodes. 

Product Type Insights

The therapeutic devices segment dominated the market with a share of 79.2% in 2022. Positive Airway Pressure devices, nasal devices, oral devices, and chin straps are some of the therapeutic devices. The rising prevalence of OSA, growing awareness levels towards OSA, continuous innovations in the form of technologically advanced devices, increasing government support & initiatives, and increasing disposable income are some of the key growth drivers.

On the other hand, the Sleep apnea masks segment is anticipated to grow at the fastest rate of 7.6%. Widespread adoption of sleep apnea masks, increasing prevalence of comorbidities associated with OSA, and rising adoption rates of CPAP machines in disease management are some of the key factors contributing to the growth of the segment.

Key players are constantly focusing on innovative product strategies to serve the growing demand. For instance, ResMed 2019 launched AirFit N30i, an advanced top-of-head-connected nasal CPAP mask for the U.S. markets with an innovative nasal cradle cushion.

Regional Insights

North America segment dominated the market with share of 48.4% in 2022. Changing lifestyles, growing disposable income, presence of renowned players, growing obese population, rising prevalence of respiratory diseases, growing awareness about OSA, and favorable government initiatives are some of the key factors driving the growth. Some of the key participants present in North America are Philips Respironics; Somnetics International Inc.; and ResMed. These companies have a strong business presence and have well-established supply & distribution channels across North America.

Asia Pacific segment is anticipated to grow at the fastest rate of 7.7% over the forecast period owing to the growing geriatric population and rising prevalence of lifestyle diseases such as cardiovascular diseases, cancer, hypertension, diabetes, and chronic respiratory diseases. As per the OECD iLibrary article on Asia/Pacific 2020, approximately 227 million individuals are diagnosed with type 2 diabetes in the Asia Pacific. The growing prevalence of chronic conditions is expected to contribute to the surge in OSA and drive the adoption of sleep apnea devices in countries in the Asia Pacific.

According to a PubMed article, the prevalence of OSA amongst middle-aged males ranges from 4.1% to 7.5%, and amongst fem, ales it ranges from 2.1% to 3.2% in the Asia Pacific. According to the Asian Pacific Society of Respirology, in May 2020, the incidence rate of mild OSA in Asia Pacific countries ranges from 7.8% in Hong Kong to 77.2% in Malaysia.

Key Companies & Market Share Insights

The key players are constantly focusing on innovative product development strategies to gain a competitive edge and expand their business footprints. The companies are devising merger & acquisitions and partnership strategies to expand their product offering and serve the growing customer pool. For instance, in February 2021, Nyxoah SA and Vanderbilt University entered a strategic partnership to develop innovative neurostimulation solutions for treating OSA. Some of the prominent players in the sleep apnea devices market include: Some prominent players in the global sleep apnea devices market include:

• ResMed

• Phillips Respironics

• Fisher & Paykel Healthcare Limited

• Curative Medical, Inc.

• Invacare Corporation

• Somnetics International, Inc.

• BMC Medical Co., Ltd.

• Natus Medical Incorporated

• SOMNOmedics GmbH

• Compumedics Limited

• Itamar Medical Ltd.

• Nihon Kohden Corporation

Recent Development

• In January 2021, ResMed made a strategic move by acquiring Ectosense to enhance its market presence and bolster the diagnosis of sleep apnea. This acquisition enables ResMed to tap into a significant underserved market, with over 80% of the global sleep apnea population, estimated at 936 million individuals, yet to be diagnosed

Sleep Apnea Devices Market Report Scope

Global Sleep Apnea Devices Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2030. For this study, Grand View Research, Inc. has segmented the global sleep apnea devices market report based on product type and region:

• Product Type Outlook (Revenue, USD Million, 2016 - 2030)

  • Diagnostic Devices

    • Actigraphs

    • Polysomnography (PSG) device

    • Respiratory Polygraphs

      • Cardiologists

      • ENT Specialists

      • Homecare Nurses

      • Sleep Physicians

    • Pulse Oximeters

  • Therapeutic Devices

    • Positive Airway Pressure (PAP) Devices

      • CPAP

      • APAP

      • Bi-PAP

    • Oral Devices

    • Nasal Devices

    • Chin Straps

  • Sleep Apnea Masks

• Regional Outlook (Revenue, USD Million, 2016 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

    • Portugal

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Singapore

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • U.A.E.